Role of Imaging as an Adjunct or Replacement for Biopsy: American Experience

[1]  Ke Sheng,et al.  Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer , 2011, Advances in urology.

[2]  M. Roethke,et al.  [MRI navigated stereotactic prostate biopsy: fusion of MRI and real-time transrectal ultrasound images for perineal prostate biopsies]. , 2012, Der Urologe. Ausg. A.

[3]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[4]  Xavier Leroy,et al.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. , 2011, Urology.

[5]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[6]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[7]  J. Kurhanewicz,et al.  Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage – impact of tissue environment , 2011, NMR in biomedicine.

[8]  Valeria Panebianco,et al.  Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. , 2011, European urology.

[9]  Thomas Hambrock,et al.  Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. , 2011, Radiology.

[10]  Aaron Fenster,et al.  Clinical application of a 3D ultrasound-guided prostate biopsy system. , 2011, Urologic oncology.

[11]  Ralph Strecker,et al.  Areas Suspicious for Prostate Cancer : MR – guided Biopsy in Patients with at Least One Transrectal US-guided Biopsy with a Negative Finding — Multiparametric MR Imaging for Detection and Biopsy Planning 1 , 2011 .

[12]  P. Choyke,et al.  Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[13]  P. López-Larrubia,et al.  Quantitative 1H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis‐set: Correlation with histologic findings , 2011, Magnetic resonance in medicine.

[14]  S. Verma,et al.  Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.

[15]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[16]  A. Verbaeys,et al.  Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients. , 2011, European journal of radiology.

[17]  Baris Turkbey,et al.  Documenting the location of prostate biopsies with image fusion , 2011, BJU international.

[18]  P. Stattin,et al.  1H HRMAS NMR Derived Bio-markers Related to Tumor Grade, Tumor Cell Fraction, and Cell Proliferation in Prostate Tissue Samples , 2011, Biomarker insights.

[19]  P. Choyke,et al.  D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. , 2010, The Journal of urology.

[20]  C. Parker,et al.  Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance. , 2011, The British journal of radiology.

[21]  S. Maier,et al.  Apparent diffusion coefficient of line scan diffusion image in normal prostate and prostate cancer--comparison with single-shot echo planner image. , 2011, Magnetic resonance imaging.

[22]  Cher Heng Tan,et al.  Diffusion weighted imaging in prostate cancer , 2011, European Radiology.

[23]  T. Ishidate,et al.  Changes in Diffusion-Weighted Images for Visualizing Prostate Cancer during Antiandrogen Therapy: Preliminary Results , 2010, Urologia Internationalis.

[24]  H. Hricak,et al.  Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging? , 2010, BJU international.

[25]  T. Miki,et al.  Technique for a hybrid system of real‐time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy , 2010, International journal of urology : official journal of the Japanese Urological Association.

[26]  R. Passariello,et al.  Role of magnetic resonance spectroscopic imaging ([1H]MRSI) and dynamic contrast-enhanced MRI (DCE-MRI) in identifying prostate cancer foci in patients with negative biopsy and high levels of prostate-specific antigen (PSA) , 2010, La radiologia medica.

[27]  C. Magi-Galluzzi,et al.  Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. , 2010, Urology.

[28]  C. McCulloch,et al.  Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection. , 2010, Radiology.

[29]  P. Carroll,et al.  Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. , 2010, Radiology.

[30]  R. Weersink,et al.  Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. , 2010, European urology.

[31]  T. H. van der Kwast,et al.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.

[32]  Roberto Passariello,et al.  Value of Magnetic Resonance Spectroscopy Imaging and Dynamic Contrast-Enhanced Imaging for Detecting Prostate Cancer Foci in Men With Prior Negative Biopsy , 2010, Clinical Cancer Research.

[33]  J. Battermann,et al.  Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. , 2010, International journal of radiation oncology, biology, physics.

[34]  Thomas Hambrock,et al.  Feasibility of 3T Dynamic Contrast-Enhanced Magnetic Resonance-Guided Biopsy in Localizing Local Recurrence of Prostate Cancer After External Beam Radiation Therapy , 2010, Investigative radiology.

[35]  H. Hricak,et al.  Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI. , 2010, Urology.

[36]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[37]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[38]  A P Labanaris,et al.  Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate , 2009, Prostate Cancer and Prostatic Diseases.

[39]  P. Carroll,et al.  Eligibility for active surveillance and pathological outcomes for men undergoing radical prostatectomy in a large, community based cohort. , 2010, The Journal of urology.

[40]  O. Rouvière,et al.  Imaging of prostate cancer local recurrences : why and how ? , 2010 .

[41]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[42]  J. Epstein,et al.  Letters to the Editor/Errata Re: Radical Prostatectomy Findings in Patients in Whom Active Surveillance of Prostate Cancer Fails , 2010 .

[43]  I. Hsu,et al.  High-dose-rate brachytherapy for localized prostate adenocarcinoma post abdominoperineal resection of the rectum and pelvic irradiation: Technique and experience. , 2009, Brachytherapy.

[44]  J. Eastham,et al.  High‐intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure , 2009, BJU international.

[45]  A Fenster,et al.  Image guided photothermal focal therapy for localized prostate cancer: phase I trial. , 2009, The Journal of urology.

[46]  Dirk F Moore,et al.  Outcomes of localized prostate cancer following conservative management. , 2009, JAMA.

[47]  L. Turnbull,et al.  Description of magnetic resonance imaging‐derived enhancement variables in pathologically confirmed prostate cancer and normal peripheral zone regions , 2009, BJU international.

[48]  Gary P Liney,et al.  Analysis of Prostate DCE-MRI: Comparison of Fast Exchange Limit and Fast Exchange Regimen Pharmacokinetic Models in the Discrimination of Malignant From Normal Tissue , 2009, Investigative radiology.

[49]  A. Evans,et al.  Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[50]  Jason A Koutcher,et al.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume. , 2009, Radiology.

[51]  S. Fosså,et al.  Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.

[52]  P. Carroll,et al.  Pathological outcomes of candidates for active surveillance of prostate cancer. , 2009, The Journal of urology.

[53]  Drew A. Torigian,et al.  MR Imaging of the Prostate Gland. , 2009, PET clinics.

[54]  Katarzyna J Macura,et al.  Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. , 2009, Radiology.

[55]  C. Gratzke,et al.  Editorial comment on: Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. , 2009, European urology.

[56]  Neil Fleshner,et al.  The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate‐specific antigen levels , 2009, BJU international.

[57]  John Kurhanewicz,et al.  Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis. , 2009, European urology.

[58]  L. Chauveinc,et al.  IRM dynamique quantitative et localisation du cancer de prostate non palpable , 2009 .

[59]  C. Kim,et al.  Prediction of locally recurrent prostate cancer after radiation therapy: Incremental value of 3T diffusion‐weighted MRI , 2009, Journal of magnetic resonance imaging : JMRI.

[60]  D. Dearnaley,et al.  Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.

[61]  J. Chapelon,et al.  Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI , 2009, European Radiology.

[62]  B. K. Park,et al.  Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience , 2010, Abdominal Imaging.

[63]  Xavier Leroy,et al.  Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.

[64]  Katarzyna J Macura,et al.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Evaluation of the Prostate , 2008, Topics in magnetic resonance imaging : TMRI.

[65]  K. Macura,et al.  Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping and Spectroscopy in Prostate Cancer , 2008, Topics in magnetic resonance imaging : TMRI.

[66]  Daniel B. Vigneron,et al.  Advances in MR spectroscopy of the prostate. , 2008, Magnetic resonance imaging clinics of North America.

[67]  A. Haese*,et al.  Currently used criteria for active surveillance in men with low‐risk prostate cancer , 2008, Cancer.

[68]  Thomas Hambrock,et al.  Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative Radiology.

[69]  John Kurhanewicz,et al.  Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. , 2008, Magnetic resonance imaging.

[70]  N. Jagannathan,et al.  Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[71]  J. Pouliot,et al.  Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[72]  N M deSouza,et al.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.

[73]  A. Hemal,et al.  Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study. , 2008, Magnetic resonance imaging.

[74]  S. Mancino,et al.  Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience , 2008, La radiologia medica.

[75]  B. K. Park,et al.  MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer. , 2008, AJR. American journal of roentgenology.

[76]  D. Stoianovici,et al.  Transperineal prostate intervention: robot for fully automated MR imaging--system description and proof of principle in a canine model. , 2008, Radiology.

[77]  Donald E Bailey,et al.  Active surveillance for early‐stage prostate cancer , 2008, Cancer.

[78]  Ying Lu,et al.  Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience. , 2008, Radiology.

[79]  Peter Guion,et al.  Initial clinical experience with real‐time transrectal ultrasonography‐magnetic resonance imaging fusion‐guided prostate biopsy , 2008, BJU international.

[80]  John Kurhanewicz,et al.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. , 2008, Journal of endourology.

[81]  Masoom A Haider,et al.  Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[82]  Jason A Koutcher,et al.  Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. , 2008, Radiology.

[83]  Nobuhiko Hata,et al.  MR‐guided prostate interventions , 2008, Journal of magnetic resonance imaging : JMRI.

[84]  Y. Liu,et al.  Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis. , 2008, Clinical radiology.

[85]  P. Carroll,et al.  Multiparametric magnetic resonance imaging in prostate cancer: present and future , 2008, Current opinion in urology.

[86]  P. Choyke,et al.  Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies , 2008, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.

[87]  Hiroshi Honda,et al.  Usefulness of apparent diffusion coefficient map in diagnosing prostate carcinoma: Correlation with stepwise histopathology , 2008, Journal of magnetic resonance imaging : JMRI.

[88]  Benjamin M Yeh,et al.  Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. , 2008, Radiology.

[89]  Piotr Kozlowski,et al.  Diffusion-weighted MRI in prostate cancer -- comparison between single-shot fast spin echo and echo planar imaging sequences. , 2008, Magnetic resonance imaging.

[90]  T. Keane,et al.  Salvage options for biochemical recurrence after primary therapy for prostate cancer. , 2007, The Canadian journal of urology.

[91]  Byung Kwan Park,et al.  Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.

[92]  Rodolfo Montironi,et al.  Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. , 2007, European urology.

[93]  Sheng Xu,et al.  Closed-Loop Control in Fused MR-TRUS Image-Guided Prostate Biopsy , 2007, MICCAI.

[94]  M. Scherr,et al.  Proton MR spectroscopy of the prostate. , 2007, European journal of radiology.

[95]  P. Carroll,et al.  The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. , 2007, The Journal of urology.

[96]  Clare Allen,et al.  Dynamic contrast enhanced MRI in prostate cancer. , 2007, European journal of radiology.

[97]  J. Kurhanewicz,et al.  Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. , 2007, Radiology.

[98]  Thomas Hambrock,et al.  Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance. , 2007, Radiology.

[99]  Esin Ozturk-Isik,et al.  High‐speed 3T MR spectroscopic imaging of prostate with flyback echo‐planar encoding , 2007, Journal of magnetic resonance imaging : JMRI.

[100]  Richard K Valicenti,et al.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[101]  M. Kattan,et al.  The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis , 2007, BJU international.

[102]  J. Pouliot,et al.  Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. , 2007, International journal of radiation oncology, biology, physics.

[103]  Benjamin M Yeh,et al.  Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. , 2007, AJR. American journal of roentgenology.

[104]  Takeo Ishigaki,et al.  Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging. , 2007, European journal of radiology.

[105]  Ying Lu,et al.  High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. , 2007, Radiology.

[106]  P. Carroll,et al.  Validity of prostate‐specific antigen as a tumour marker in men with prostate cancer managed by watchful‐waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging , 2007, BJU international.

[107]  Alexandru Patriciu,et al.  “MRI Stealth” robot for prostate interventions , 2007, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[108]  E W Steyerberg,et al.  Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. , 2006, The Journal of urology.

[109]  H. Hricak,et al.  Incremental value of multiplanar cross-referencing for prostate cancer staging with endorectal MRI. , 2007, AJR. American journal of roentgenology.

[110]  Michael W Kattan,et al.  Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. , 2007, Radiology.

[111]  Olivier Rouvière,et al.  Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? , 2007, European Radiology.

[112]  Jelle O. Barentsz,et al.  Prostate cancer: comparison of local staging accuracy of pelvic phased-array coil alone versus integrated endorectal–pelvic phased-array coils , 2007, European Radiology.

[113]  J. Kurhanewicz,et al.  Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score , 2007, European Radiology.

[114]  E. Squillaci,et al.  In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging , 2006, La radiologia medica.

[115]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[116]  Clare Allen,et al.  How good is MRI at detecting and characterising cancer within the prostate? , 2006, European urology.

[117]  M. Terris,et al.  Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy , 2006, Cancer.

[118]  Shugo Suzuki,et al.  Pitfalls with MRI Evaluation of Prostate Cancer Detection , 2006, Urologia Internationalis.

[119]  H. Huisman,et al.  Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. , 2006, Radiology.

[120]  Mauricio Castillo,et al.  Clinical role of proton magnetic resonance spectroscopy in oncology: brain, breast, and prostate cancer. , 2006, The Lancet. Oncology.

[121]  Heinz-Peter Schlemmer,et al.  MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. , 2006, European urology.

[122]  Yasunari Fujiwara,et al.  KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties. , 2006, Cancer research.

[123]  G. Gualdi,et al.  Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging , 2006, Abdominal Imaging.

[124]  Jocelyne Troccaz,et al.  MRI/TRUS data fusion for brachytherapy , 2006, The international journal of medical robotics + computer assisted surgery : MRCAS.

[125]  Silvia D. Chang,et al.  Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.

[126]  A. Hemal,et al.  Original contributions Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level , 2006 .

[127]  Evis Sala,et al.  Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. , 2006, Radiology.

[128]  Chris J. Diederich,et al.  Magnetic Resonance-Guided High-Intensity Ultrasound Ablation of the Prostate , 2006, Topics in magnetic resonance imaging : TMRI.

[129]  Stephan E Maier,et al.  Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range. , 2006, Magnetic resonance imaging.

[130]  Tom W J Scheenen,et al.  IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. , 2006, International journal of radiation oncology, biology, physics.

[131]  John Kurhanewicz,et al.  Quantification of prostate MRSI data by model‐based time domain fitting and frequency domain analysis , 2006, NMR in biomedicine.

[132]  B. Taouli.  Le rôle de la spectroscopie IRM dans l'évaluation du cancer de la prostate , 2006 .

[133]  H. Mertens,et al.  Stellenwert der Diffusionsbildgebung in der Diagnostik von Wirbelkörpermetastasen des Prostatakarzinoms im Vergleich zu anderen Primärtumoren , 2006 .

[134]  M. Kattan,et al.  Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. , 2006, Radiology.

[135]  L. Turnbull,et al.  Diffusion‐weighted imaging of normal and malignant prostate tissue at 3.0T , 2006, Journal of magnetic resonance imaging : JMRI.

[136]  L. Turnbull,et al.  Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.

[137]  E. Squillaci,et al.  Magnetic resonance imaging of the prostate with spectroscopic imaging using a surface coil. Initial clinical experience , 2006, La radiologia medica.

[138]  C. Kim,et al.  Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.

[139]  P. Carroll,et al.  Prostate cancer: endorectal MR imaging and MR spectroscopic imaging--distinction of true-positive results from chance-detected lesions. , 2006, Radiology.

[140]  Evis Sala,et al.  Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. , 2006, Radiology.

[141]  P. Carroll,et al.  Magnetic resonance imaging and spectroscopy of prostate cancer. , 2006, Reviews in urology.

[142]  C. N. Coleman,et al.  Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. , 2006, The Journal of urology.

[143]  B. Kiefer,et al.  Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device , 2006, European Radiology.

[144]  Steven J Haker,et al.  Magnetic resonance spectroscopy-guided transperineal prostate biopsy and brachytherapy for recurrent prostate cancer. , 2005, Urology.

[145]  D. Beyersdorff,et al.  MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging. , 2005, AJR. American journal of roentgenology.

[146]  Seong Ho Park,et al.  Wash‐in rate on the basis of dynamic contrast‐enhanced MRI: Usefulness for prostate cancer detection and localization , 2005, Journal of magnetic resonance imaging : JMRI.

[147]  J. Kurhanewicz,et al.  Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. , 2005, Radiology.

[148]  Dennis W J Klomp,et al.  Optimal timing for in vivo 1H‐MR spectroscopic imaging of the human prostate at 3T , 2005, Magnetic resonance in medicine.

[149]  Robert J Gillies,et al.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. , 2005, Neoplasia.

[150]  P. Carroll.  Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both? , 2005, The Journal of urology.

[151]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[152]  D. Katz,et al.  Prospective CT diagnosis of stump appendicitis. , 2005, AJR. American journal of roentgenology.

[153]  Vladimir Bilim,et al.  Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) is a useful modality for the precise detection and staging of early prostate cancer , 2005, The Prostate.

[154]  J Kurhanewicz,et al.  Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI , 2005, Magnetic resonance in medicine.

[155]  Gabor Fichtinger,et al.  Design of a novel MRI compatible manipulator for image guided prostate interventions , 2005, IEEE Transactions on Biomedical Engineering.

[156]  Peter B Barker,et al.  Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study , 2005, Journal of magnetic resonance imaging : JMRI.

[157]  J. Pauly,et al.  Design of flyback echo-planar readout gradients for MR spectroscopic imaging , 2005 .

[158]  J. Kurhanewicz,et al.  Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[159]  J. Kurhanewicz,et al.  Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. , 2004, Radiology.

[160]  V. Pansadoro,et al.  Prostate cancer: evaluation with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 2004, La Radiologia medica.

[161]  N. Moriyama,et al.  Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. , 2004, Japanese journal of clinical oncology.

[162]  C. N. Coleman,et al.  System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner , 2004, Magnetic resonance in medicine.

[163]  Mark Rijpkema,et al.  Combined quantitative dynamic contrast‐enhanced MR imaging and 1H MR spectroscopic imaging of human prostate cancer , 2004, Journal of magnetic resonance imaging : JMRI.

[164]  A. Svindland,et al.  Dynamic first pass 3D EPI of the prostate: accuracy in tumor location , 2004, Acta radiologica.

[165]  J. Pouliot,et al.  Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging. , 2004, International journal of radiation oncology, biology, physics.

[166]  J. Pauly,et al.  Design of symmetric‐sweep spectral‐spatial RF pulses for spectral editing , 2004, Magnetic resonance in medicine.

[167]  Michael W Kattan,et al.  Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. , 2004, Radiology.

[168]  J. Kurhanewicz,et al.  Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging. , 2004, International journal of radiation oncology, biology, physics.

[169]  Chinyere N. Onyebuchi,et al.  The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy , 2004, Cancer.

[170]  Jocelyne Troccaz,et al.  MRI/TRUS data fusion for prostate brachytherapy. Preliminary results , 2004, Medical physics.

[171]  W S Ng,et al.  Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. , 2004, The Journal of urology.

[172]  H. Schlemmer,et al.  Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004, European Radiology.

[173]  A. Hemal,et al.  Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate , 2004, Urological Research.

[174]  H. Schlemmer,et al.  Dynamic Magnetic Resonance Tomography and Proton Magnetic Resonance Spectroscopy of Prostate Cancers in Rats Treated by Radiotherapy , 2004, Investigative radiology.

[175]  P. Carroll,et al.  Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. , 2004, Radiology.

[176]  E. Small,et al.  Role of secondary hormonal therapy in the management of recurrent prostate cancer. , 2003, Urology.

[177]  J. Waterton,et al.  Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours , 2003, British Journal of Cancer.

[178]  K. Yamada,et al.  Visualization of prostate cancer using dynamic contrast-enhanced MRI: comparison with transrectal power Doppler ultrasound. , 2003, The British journal of radiology.

[179]  Kazuto Ito,et al.  The combination of multi-voxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. , 2003, Anticancer research.

[180]  William Wells,et al.  Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.

[181]  R. Franklin,et al.  Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. , 2003, Journal of inorganic biochemistry.

[182]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[183]  Pierre I Karakiewicz,et al.  Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. , 2003, European urology.

[184]  Robert W Veltri,et al.  Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. , 2003, The Journal of urology.

[185]  Derek K Jones,et al.  Applications of diffusion‐weighted and diffusion tensor MRI to white matter diseases – a review , 2002, NMR in biomedicine.

[186]  M. Moseley.  Diffusion tensor imaging and aging – a review , 2002, NMR in biomedicine.

[187]  C. Sotak,et al.  The role of diffusion tensor imaging in the evaluation of ischemic brain injury – a review , 2002, NMR in biomedicine.

[188]  R. Kikinis,et al.  Diffusion tensor imaging and its application to neuropsychiatric disorders. , 2002, Harvard review of psychiatry.

[189]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[190]  Peter H Gann,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.

[191]  Silvia D. Chang,et al.  Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. , 2002, Radiology.

[192]  A. Padhani,et al.  Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.

[193]  Kazuto Ito,et al.  MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. , 2002, Anticancer research.

[194]  Cedric Yu,et al.  Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. , 2001, International journal of radiation oncology, biology, physics.

[195]  J. Pauly,et al.  Dualband spectral‐spatial RF pulses for prostate MR spectroscopic imaging , 2001, Magnetic resonance in medicine.

[196]  Peter Gibbs,et al.  Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.

[197]  J Kurhanewicz,et al.  Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. , 2001, Radiology.

[198]  P. Carroll,et al.  Spectroscopy in prostate cancer: hope or hype? , 2001, Oncology.

[199]  M. Rifkin,et al.  Should Ultrasound Criteria of the Prostate Be Redefined to Better Evaluate When and Where to Biopsy , 2001, Ultrasound quarterly.

[200]  B Pickett,et al.  Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. , 2001, International journal of radiation oncology, biology, physics.

[201]  A W Partin,et al.  Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.

[202]  J Kurhanewicz,et al.  Time‐dependent effects of hormone‐deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging , 2001, Magnetic resonance in medicine.

[203]  A. D'Amico,et al.  MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. , 2001, Radiology.

[204]  N Sailasuta,et al.  Single‐voxel oversampled J‐resolved spectroscopy of in vivo human prostate tissue , 2001, Magnetic resonance in medicine.

[205]  N Hata,et al.  Feasibility of transperineal prostate biopsy under interventional magnetic resonance guidance. , 2000, Urology.

[206]  A. D'Amico,et al.  Transperineal magnetic resonance image guided prostate biopsy. , 2000, The Journal of urology.

[207]  J Kurhanewicz,et al.  Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.

[208]  M. Zaider,et al.  Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. , 2000, International journal of radiation oncology, biology, physics.

[209]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[210]  J. Kurhanewicz,et al.  Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer , 2000, Magnetic resonance in medicine.

[211]  Bettuzzi Saverio,et al.  Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. , 2000 .

[212]  J Kurhanewicz,et al.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.

[213]  H. Hricak,et al.  Radiologic anatomy of the prostate gland: a clinical approach. , 2000, Radiologic clinics of North America.

[214]  P. Carroll,et al.  Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.

[215]  J Kurhanewicz,et al.  Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.

[216]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[217]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[218]  R. Franklin,et al.  Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer , 1998, The Prostate.

[219]  W. Fair,et al.  Incidence and clinical significance of false-negative sextant prostate biopsies. , 1998, The Journal of urology.

[220]  C. Magi-Galluzzi,et al.  Apoptosis in Prostatic Adenocarcinoma following Complete Androgen Ablation , 1998, Urologia Internationalis.

[221]  J. Kurhanewicz,et al.  Detection of recurrent prostate cancer after cryosurgery. , 1998, Current opinion in urology.

[222]  J R Thornbury,et al.  Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.

[223]  R Alagappan,et al.  Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. , 1997, Radiology.

[224]  Robert G. Moore,et al.  Initial clinical experience , 1997 .

[225]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[226]  P. Carroll,et al.  Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. , 1996, Urology.

[227]  G P Liney,et al.  Comparison of conventional single echo and multi‐echo sequences with a fast spin‐echo sequence for quantitative T2 mapping: Application to the prostate , 1996, Journal of magnetic resonance imaging : JMRI.

[228]  P. Carroll,et al.  Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. , 1996, AJR. American journal of roentgenology.

[229]  J R Thornbury,et al.  Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. , 1996, AJR. American journal of roentgenology.

[230]  J Kurhanewicz,et al.  Prostate carcinoma: MR imaging findings after cryosurgery. , 1996, Radiology.

[231]  P. Carroll,et al.  Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. , 1996, Radiology.

[232]  R. Kikinis,et al.  Superconducting open-configuration MR imaging system for image-guided therapy. , 1995, Radiology.

[233]  P. Carroll,et al.  Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal--pelvic phased-array coils. , 1994, Radiology.

[234]  R. Franklin,et al.  Bioenergetic theory of prostate malignancy , 1994, The Prostate.

[235]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[236]  D. Chan,et al.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.

[237]  P. Scardino,et al.  Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens. , 1992, The Journal of urology.

[238]  G. Barker,et al.  The MRI measurement of NMR and physiological parameters in tissue to study disease process. , 1991, Progress in clinical and biological research.

[239]  R. Franklin,et al.  Concepts of citrate production and secretion by prostate: 2. Hormonal relationships in normal and neoplastic prostate , 1991, The Prostate.

[240]  H Y Kressel,et al.  Prostatic carcinoma: staging with MR imaging at 1.5 T. , 1988, Radiology.

[241]  L. Axel,et al.  Prostatic disorders: MR imaging at 1.5 T. , 1987, Radiology.

[242]  T. Stamey,et al.  The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation. , 1987, Radiology.

[243]  R B Jeffrey,et al.  Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. , 1987, Radiology.

[244]  H. Hricak,et al.  MR imaging of the prostate gland: normal anatomy. , 1987, AJR. American journal of roentgenology.